Purchases and Sales Made in Q2 2021 in Nova Bay Pharmaceuticals, Inc. (NBY)
This table provides information about the institutional ownership of Nova Bay Pharmaceuticals, Inc. (NBY) during Q2 2021. The information is specifically focused on institutions that hold shares of NovaBay Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
485KNew |
$296K - $470K
|
485K
$315K
|
|
|
Aug 05, 2021
Q2 2021
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
110KNew |
$67.2K - $107K
|
110K
$71.6K
|
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
BUY
|
- |
33.6K+ 140.08% |
$20.5K - $32.6K
|
57.6K
$37.4K
|
|
|
Aug 16, 2021
Q2 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
18.9K+ 25.81% |
$11.5K - $18.3K
|
91.9K
$59.7K
|
|
|
Aug 11, 2021
Q2 2021
|
Commonwealth Equity Services, LLC
|
BUY
|
- |
10KNew |
$6.12K - $9.73K
|
10K
$6.52K
|
|
|
Sep 13, 2021
Q2 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
3.01KNew |
$1.84K - $2.92K
|
3.01K
$1.96K
|
|
|
Aug 11, 2021
Q2 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
657New |
$401 - $637
|
657
$427
|
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-1- 0.58% |
$0.61 - $0.97
|
170
$111
|
|
|
Aug 06, 2021
Q2 2021
|
Fifth Third Bancorp
|
SELL
|
- |
-1KClosed |
$610 - $970
|
0
$0
|
|
|
Sep 17, 2021
Q2 2021
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-18.6K- 59.37% |
$11.4K - $18.1K
|
12.7K
$8.28K
|
|
|
Aug 16, 2021
Q2 2021
|
Squarepoint Ops LLC
New York, NY |
SELL
|
- |
-39.8KClosed |
$24.3K - $38.6K
|
0
$0
|
|
|
Aug 06, 2021
Q2 2021
|
High Tower Advisors, LLC
Chicago, IL |
SELL
|
- |
-42KClosed |
$25.6K - $40.7K
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-170K- 52.31% |
$104K - $165K
|
155K
$101K
|